Early recognition of cardiac sarcoidosis (CS) is important to initiate early treatment and prevent heart failure and sudden cardiac death. However, diagnosis of CS can be challenging and requires a high-index of suspicion. Cardiac magnetic resonance imaging (CMR) and 18F-fluorodeoxyglucose PET (18F FDG PET) have opened new avenues in the detection of CS. Experience with hybrid PET/MRI at our institution demonstrates improved workflow, decreased patient radiation exposure (compared to PET/CT) and incremental diagnostic value in imaging of CS. Both modalities are complementary, and offer important diagnostic and prognostic clinical data.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords